Is Xyzal Safe for Seniors? Side Effects and Fall Risk

Xyzal (levocetirizine) is generally considered safe for older adults and does not carry the same warnings that older allergy medications like Benadryl do. It belongs to the second-generation class of antihistamines, which were specifically designed to cause less sedation and cognitive impairment than their predecessors. That said, “generally safe” is not the same as “take it without thinking,” and kidney function turns out to be a more important variable than age itself when it comes to how seniors handle this drug.

Why Xyzal Is Not in the Same Category as Benadryl

The conversation about antihistamine safety in seniors often starts with a blanket warning about allergy pills and drowsiness. That warning is well earned, but it applies most forcefully to first-generation antihistamines like diphenhydramine (Benadryl), chlorpheniramine, and hydroxyzine. These drugs cross readily into the brain, where they block histamine receptors involved in wakefulness and cognition. A systematic review and meta-analysis found that first-generation antihistamine use roughly doubled the risk of injurious falls or fractures in older adults, with an odds ratio of about 2.0.¹ When the analysis included studies that mixed antihistamine generations or did not specify which generation was used, the association was even stronger, with nearly a threefold increase in fall risk during hospitalization.

Xyzal sits in a different pharmacological class. Second-generation antihistamines like levocetirizine were engineered to have limited penetration into the central nervous system. They still block the same histamine receptors on blood vessels and in the airways, which is what stops allergy symptoms, but they do not flood the brain the way diphenhydramine does. This distinction matters enormously for seniors, because it is the brain-penetrating effect that drives the sedation, confusion, and impaired balance that lead to falls.

The Sedation Question

Levocetirizine is not completely free of sedation risk. In a large prescription-event monitoring study in England, drowsiness or sedation was reported by about 0.37% of levocetirizine users, compared to 0.08% for desloratadine, another second-generation antihistamine.² That difference was statistically meaningful, and it places levocetirizine on the slightly more sedating end of the second-generation spectrum. Desloratadine and fexofenadine tend to score lowest on sedation measures, while levocetirizine and cetirizine score a touch higher.

Still, perspective matters here. Less than four in a thousand users reported drowsiness with levocetirizine. Compare that to diphenhydramine, where drowsiness is so common that the drug is marketed as a sleep aid (Tylenol PM, ZzzQuil). The sedation rate with first-generation drugs can run anywhere from 10% to over 50% depending on the dose and the study. So while levocetirizine is not the least sedating option on the shelf, it occupies a different universe from the drugs that generate most of the concern about older adults and antihistamines.

Individual sensitivity varies, though. Some seniors notice more drowsiness than average with any antihistamine, particularly if they take it alongside other medications that have sedating properties, like certain antidepressants, sleep aids, or opioid pain medications. If you are trying Xyzal for the first time, taking it at bedtime lets you assess whether it makes you drowsy without discovering that lesson while driving or climbing stairs.

Does Xyzal Impair Thinking or Reaction Time?

Falls are not only about sleepiness. They are also about slowed reaction time, impaired attention, and poor balance, all of which can stem from a drug’s effects on the brain. This is one area where levocetirizine has reassuring data. A study comparing levocetirizine (5 mg) to diphenhydramine (50 mg) and placebo found that memory, attention, and psychomotor tracking were all unaffected by levocetirizine after both single and repeated doses. Diphenhydramine, by contrast, significantly impaired divided attention and tracking performance after just one dose.³

A separate trial tested levocetirizine, cetirizine, and loratadine against placebo using a battery of cognitive and psychomotor tests on both the first day and the fourth day of use. None of the three antihistamines could be distinguished from placebo on any objective or subjective measure at any time point.⁴ These were conducted in healthy volunteers rather than specifically in elderly populations, but the results are consistent with what the pharmacology predicts: a drug that largely stays out of the brain should not impair cognition.

Injury Risk in Real-World Use

Lab tests of cognition and reaction time are useful, but the real concern for seniors is whether taking an antihistamine like Xyzal translates into more injuries in everyday life. A large nationwide cohort study from Japan addressed this directly. Researchers grouped second-generation antihistamines into a “higher-sedation” category (including cetirizine, levocetirizine, loratadine, olopatadine, and bepotastine) and a “lower-sedation” category (fexofenadine, bilastine, and desloratadine), based on how much each drug occupied histamine receptors in the brain. After statistical adjustment, the injury rate was identical between the two groups: 2.6% in each. Subgroup analysis by age showed consistent results across all age groups studied.⁵

This is an important finding because it means that even among second-generation antihistamines, the small differences in sedation potential that show up in monitoring studies do not appear to produce measurable differences in real-world injuries. Levocetirizine may make you slightly sleepier than fexofenadine in a head-to-head comparison, but that marginal drowsiness does not seem to be the kind that sends people to the emergency room. The evidence is fairly clear that the real fall-risk culprit in the antihistamine category is the first-generation drugs, not the second-generation ones.

Kidney Function Matters More Than Your Birthday

Here is where the safety picture for seniors gets more nuanced. Levocetirizine is the active form of cetirizine, and both are eliminated primarily through the kidneys. A pharmacokinetic study of cetirizine in elderly subjects found that the drug’s elimination half-life was significantly prolonged and total body clearance was significantly reduced compared to younger adults. At first glance, that sounds like a straightforward age effect. But the same study showed that when researchers accounted for kidney function, the relationship between age and drug clearance disappeared. The drug’s behavior depended on how well the kidneys were working, not on how old the person was.⁶

This distinction has real practical consequences. A 75-year-old with healthy kidneys processes levocetirizine much like a younger adult does. But a 65-year-old with moderate chronic kidney disease might accumulate the drug to levels where side effects become more likely. Kidney function tends to decline gradually with age, and many older adults have some degree of reduced kidney function without realizing it. The standard Xyzal dose for adults is 5 mg once daily, but prescribing guidelines recommend reducing the dose for people with moderate kidney impairment and avoiding the drug entirely in severe kidney disease.

Since kidney function is not something you can feel, it is worth knowing where yours stands if you plan to use levocetirizine regularly. A simple blood test, usually part of routine lab work at a physical, provides the estimated filtration rate that determines whether you need a dose adjustment. If you have never had your kidney function checked or if your doctor has mentioned even mildly reduced function, that is worth flagging before starting Xyzal.

The Beers Criteria and What Geriatricians Watch For

The American Geriatrics Society maintains a list called the Beers Criteria, which catalogs medications that are potentially inappropriate for adults 65 and older. This list is widely used by doctors, pharmacists, and nursing facilities as a screening tool.⁷ First-generation antihistamines like diphenhydramine and hydroxyzine are prominently featured on the Beers list due to their strong anticholinergic effects, which can cause confusion, urinary retention, constipation, and increased fall risk in older adults.

Second-generation antihistamines like levocetirizine are not flagged the same way. They lack the strong anticholinergic activity that makes first-generation drugs so problematic in seniors. This does not mean geriatricians give them an unconditional green light. Any medication that has even mild sedating potential warrants attention when prescribed to someone who is already on multiple drugs, has balance issues, or has cognitive concerns. But levocetirizine is not in the “avoid if possible” category that diphenhydramine occupies. That distinction matters if you are choosing between allergy medications and weighing the risks.

Drug Interactions and the Over-the-Counter Trap

One underappreciated risk for seniors taking Xyzal has nothing to do with Xyzal itself and everything to do with what else is in the medicine cabinet. Older adults tend to take more medications than younger people, and each additional drug increases the chance of interactions. A study examining over-the-counter medication use in older adults found that at least one instance of potential misuse occurred in 95% of participants. About 80% of participants selected an OTC product that could cause a drug-drug interaction with their existing medication regimen.⁸

Levocetirizine can contribute to this problem in a few ways. Its mild sedating potential can stack with sedation from other common medications, including certain blood pressure drugs, antidepressants, anti-anxiety medications, muscle relaxants, and prescription sleep aids. Alcohol amplifies the effect further. A senior who experiences no drowsiness from Xyzal alone might notice significant sedation when it is combined with one or two other mildly sedating drugs. This additive effect is harder to spot because no single medication seems to be the problem.

The same study noted that drug-age interactions were extremely common, affecting a majority of participants who selected sleep medications. The lesson extends to allergy medications: an OTC product that works fine for a 40-year-old may behave differently in a 75-year-old with slower metabolism, reduced kidney function, and five other prescriptions. Telling your pharmacist about everything you take, including supplements and OTC products, is not excessive caution; it is the single most effective safety check available.

When a Different Antihistamine Might Be the Better Call

If you are a senior and sedation is your primary concern, whether because you have a history of falls, drive frequently, or take other sedating medications, fexofenadine (Allegra) or desloratadine (Clarinex) sit at the least-sedating end of the second-generation spectrum. The prescription-event monitoring data showed desloratadine’s drowsiness rate to be roughly a fifth of levocetirizine’s, and the Japanese injury cohort study grouped fexofenadine in the lowest-sedation tier.² That said, the real-world injury data did not show a difference between higher- and lower-sedation second-generation drugs, so the practical gap between these medications may be smaller than the lab measurements suggest.⁵

Levocetirizine does have some advantages that keep it in the conversation for older patients. It tends to be effective for hives (chronic urticaria) in ways that some of the less-sedating alternatives are not. If your allergy symptoms have not responded well to fexofenadine or loratadine, levocetirizine may be worth the marginally higher sedation profile. The choice is not between “safe” and “dangerous” within the second-generation class. It is more like choosing between options that are all quite safe, with small trade-offs in sedation profile, efficacy for specific conditions, and how they interact with your kidney function.

Adjusting the Dose When Kidneys Are Not at Full Capacity

Because levocetirizine is cleared through the kidneys, dose adjustments become important when kidney function drops below normal. The standard adult dose is 5 mg once daily. For mild kidney impairment, that dose usually does not need to change. For moderate impairment, the recommended dose drops to 2.5 mg once daily. For severe impairment, 2.5 mg every other day is sometimes used, though some clinicians prefer to switch to a different antihistamine altogether at that point. In patients on dialysis or with end-stage kidney disease, levocetirizine is generally avoided.

The pharmacokinetic data support this approach. When the kidneys clear the drug more slowly, each dose hangs around longer in the bloodstream, effectively giving you a higher exposure than intended. That prolonged exposure can increase the chance of drowsiness, dry mouth, and fatigue, the same side effects that raise concerns about fall risk in older adults.⁶ In seniors with chronic kidney disease, this principle applies broadly: many common medications need dose adjustments, and antihistamines are no exception. A review of renally inappropriate medication use in older adults underscored that patients with chronic kidney disease who take improperly dosed medications face higher rates of adverse reactions and hospitalizations.⁹

What the First-Generation Comparison Reveals About Risk Perception

One reason the question “Is Xyzal safe for seniors?” comes up so often is that people have absorbed a general message that antihistamines are risky for older adults. That message is accurate but imprecise. The risk is overwhelmingly concentrated in first-generation drugs. The meta-analysis finding that first-generation antihistamines doubled the odds of injurious falls or fractures in elderly patients is a substantial effect size, comparable to the fall risk associated with benzodiazepines and some sedative-hypnotics.¹ When studies lumped all antihistamine generations together or focused on hospitalized patients without specifying which drugs were used, the association climbed even higher, suggesting that first-generation drugs were driving most of the signal.

The problem is that many seniors still reach for diphenhydramine, either for allergies or for sleep, because it is cheap, familiar, and available everywhere. Some combination cold-and-flu products contain first-generation antihistamines without making that especially obvious on the label. If you are over 65 and concerned about antihistamine safety, the most impactful single step is checking whether any of your current medications, prescribed or over the counter, are first-generation antihistamines and discussing alternatives with your doctor. Swapping from Benadryl to Xyzal is not trading one risk for a slightly different one. It is moving from a drug class with well-documented fall risk to one where that risk largely disappears.